Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Seeger

Showing results (151-160 of 266) with videos related to

Pageof 27
Sort By:
Journal of Pediatric Hematology/Oncology|August 26, 2000
Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonusN L Antunes, Y Khakoo, K K Matthay, et al.
Journal of Virology|January 11, 2000
Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infectionsJ T Guo, H Zhou, C Liu, et al.
Lancet (London, England)|August 13, 1983
Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study GroupP M Zeltzer, P J Marangos, A M Parma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantationJ G Villablanca, A A Khan, V I Avramis, et al.
Journal of Pediatric Surgery|September 1, 1991
Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastomaG M Haase, M C O'Leary, N K Ramsay, et al.
Cancer Research|December 14, 2018
Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape MechanismsPaolo Neviani, Petra M Wise, Mariam Murtadha, et al.
Cancer Research|February 24, 2001
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastomaP M Thompson, J M Maris, M D Hogarty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group StudyMary Lou Schmidt, Ashutosh Lal, Robert C Seeger, et al.
Journal of the National Cancer Institute|September 7, 2006
Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplificationShahab Asgharzadeh, Roger Pique-Regi, Richard Sposto, et al.
Journal of Virology|April 1, 1991
Woodchuck hepatitis virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in a common hostC Seeger, B Baldwin, W E Hornbuckle, et al.
Pageof 27

Showing results (151-160 of 266) with videos related to

Sort By:
Pageof 27
Journal of Pediatric Hematology/Oncology|August 26, 2000
Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonusN L Antunes, Y Khakoo, K K Matthay, et al.
Journal of Virology|January 11, 2000
Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infectionsJ T Guo, H Zhou, C Liu, et al.
Lancet (London, England)|August 13, 1983
Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study GroupP M Zeltzer, P J Marangos, A M Parma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantationJ G Villablanca, A A Khan, V I Avramis, et al.
Journal of Pediatric Surgery|September 1, 1991
Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastomaG M Haase, M C O'Leary, N K Ramsay, et al.
Cancer Research|December 14, 2018
Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape MechanismsPaolo Neviani, Petra M Wise, Mariam Murtadha, et al.
Cancer Research|February 24, 2001
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastomaP M Thompson, J M Maris, M D Hogarty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group StudyMary Lou Schmidt, Ashutosh Lal, Robert C Seeger, et al.
Journal of the National Cancer Institute|September 7, 2006
Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplificationShahab Asgharzadeh, Roger Pique-Regi, Richard Sposto, et al.
Journal of Virology|April 1, 1991
Woodchuck hepatitis virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in a common hostC Seeger, B Baldwin, W E Hornbuckle, et al.
Pageof 27